Morgan Stanley
SCR

Morgan Stanley’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Morgan Stanley’s Portfolio SCR Stock Details SCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,143
Closed -$11K – 6767
2013
Q4 		$11K Buy
+1,143
New +$10.9K ﹤0.01% 6037

Morgan Stanley's SCR Position: Q1 2014 in Review

Morgan Stanley sold out of SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) in Q1 2014, closing a stake of 1,143 shares — an estimated $11K sold.

Morgan Stanley first reported a position in SCR in Q4 2013 and held it in 1 quarter. The position peaked at $11K in Q4 2013. 0 funds tracked by Wall St. Rank hold SCR as of Q1 2014.

  • Morgan Stanley reported no remaining SIMCERE PHARMACEUTICAL GROUP, ADS position as of Q1 2014 after selling out during the quarter.
  • Morgan Stanley sold 1,143 SIMCERE PHARMACEUTICAL GROUP, ADS shares in Q1 2014, an estimated $11K.
  • Morgan Stanley first reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS in Q4 2013 and held it in 1 quarter.
  • Morgan Stanley's SIMCERE PHARMACEUTICAL GROUP, ADS position peaked at $11K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held SIMCERE PHARMACEUTICAL GROUP, ADS as of Q1 2014.

Based on Morgan Stanley's 13F filing for Q1 2014, filed 13 May 2014.